Stock Rich List
#4212 on the rich list of 14,452 insiders

Philip Astley-Sparke

Director at Replimune Group; Director at enGene Therapeutics. Based in Woburn, Massachusetts.

$26.2M
in disclosed stock, −$792K (−2.93%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
4212th of 14,452
Companies held
2
Largest holding
REPL, 99.9% of total
Latest SEC filing
Aug 20, 2026

What the $26.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Replimune Group REPL
Common Stock
Directly1,362,414$19.23$26.2M99.9%Form 4, Aug 20, 2026
enGene Therapeutics ENGN
Common Shares
Directly20,000$1.76$35K0.1%Form 3, Jul 8, 2025

Share counts are the amounts Philip Astley-Sparke reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 18, 2026SoldREPL17,657$5.08$90KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4209Charles A. Bacon III
Director, Limbach Holdings. Warrendale, PA
$26.3M−$1.1M (−4.04%)
4210Robert W. Scully
Director, KKR & Co.
$26.3M−$383K (−1.44%)
4211Suying Liu
CEO and CFO, Mountain Crest Acquisition 6. New York, NY
$26.3M$0 (0.00%)
4212Philip Astley-Sparke
Director, Replimune Group. Woburn, MA
$26.2M−$792K (−2.93%)
4213Ken Takanashi
Director, Wave Life Sciences
$26.2M−$482K (−1.81%)
4214Gayn Erickson
President and CEO, Aehr Test Systems. Fremont, CA
$26.2M−$842K (−3.11%)
4215John E. Sanfilippo
Director, John B. Sanfilippo & Son. Elgin, IL
$26.2M−$190K (−0.72%)

Other Replimune Group insiders

All REPL insiders

Questions

How much stock does Philip Astley-Sparke own?

Philip Astley-Sparke holds $26,234,421 in listed stock based on SEC filings and current prices, mostly Replimune Group (REPL). That ranks 4212th on the Stock Rich List.

Is this Philip Astley-Sparke's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Philip Astley-Sparke last buy or sell stock?

The most recent open-market trade on file is a sale of 17,657 REPL shares on May 18, 2026 at $5.08.